| http://www.w3.org/ns/prov#value | - On October 2, 2012, we entered into a Right of First Negotiation Agreement (the ???ROFN Agreement???) with Celgene Corporation (???Celgene???), one of the selling stockholders, pursuant to which we granted Celgene a right of first negotiation to the license, sale, assignment, transfer or other disposition by us of any material portion of intellectual property (including patents and trade secrets)
|
